Children’s Hospital Los Angeles is accredited by the Institute for Medical Quality / California Medical Association (IMQ/CMA) to provide continuing medical education for physicians. Children’s Hospital Los Angeles takes responsibility for the content, quality and scientific integrity of this CME activity. Children’s Hospital Los Angeles designates this “58th Clinical Conference in Pediatric Anesthesiology” for a maximum of 13.5 hours AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education. 2020 Conference attendees should be aware of current procedures for obtaining their CME credit. Attendees must complete and submit an evaluation via registration website as documentation of the sessions that were actually attended. Submitting the evaluation also functions as verification of your attendance at the meeting. CME/CEU certificates will not be generated without submission of evaluation. To comply with current policies of the ACGME and the American Medical Association, The Pediatric Anesthesiology Foundation will award CME certificates noting the actual number of hours that each physician participated in educational activities. Certificates will be available for printing after evaluations have been submitted. Printing of certificates will be the responsibility of each participant.

Read on pediatric-anesthesiology-foundation.com

This is a three-day, in-depth course that precedes the NAEMSP® Annual Meeting.  More information regarding this course will be posted as it becomes available.

Read on naemsp.org

What Types of RI Should Your Company Use?

The types of regulatory intelligence (RI) we use vary as widely as the products we work with. This virtual event will provide an overview of the different types and uses of RI, how to effectively locate RI, and how to manage RI. The skills you’ll learn over the course of this event will help you achieve desired business outcomes and avoid unpleasant surprises late in the product development cycle. Best of all, the programming is split into two half-day sessions, giving you back a few hours each day.

<a target="_blank" href=https://contentsharing.net/actions/email_web_version.cfm?recipient_id=4514295223&message_id=17802428&user_id=RAPS&group_id=5670086&jobid=46146441>Read on contentsharing.net

The MedTech Impact Challenge is a newly developed competition, engineered to highlight and reward innovation in the rapidly emerging market of digital medical technology. This first-ever industry competition will culminate in an impressive award recognition ceremony at the 2019 MedTech Impact Expo & Conference.

Produced by MedTech Impact on Wellness, this unique competition encourages innovation, and accomplishes a quadruple objective: enhancing the patient experience; improving population health; reducing overall burdensome costs; and improving the work life of health care providers, clinicians, and staff.

Read on medtechimpact.com

The Digital Healthcare Innovation Summit (DHIS) unites the investors, entrepreneurs, providers, payers, and industry leaders who are creating the digital tools that create new therapies and deliver more efficient – and effective – care to patients. Attendees will have the opportunity to network with decision makers from across healthcare.

Read on dhis.net

The call for evidence in digital medicine is getting louder and the movement is gaining momentum. Join NODE.Health for the third annual Digital Medicine Conference where we will convene the leaders driving the movement to bring the rigor of evidence-based medicine to digital health. The number of digital tools and applications available to reduce inefficiencies, improve access, reduce cost, increase quality, and make medicine more personalized for patients is growing exponentially. However, the tools and standards to evaluate their safety and efficacy are not well established. Through the Digital Medicine Conference, NODE.Health aims to bring structure, scalability, and reliability to the digital medicine validation process. Join us along with over 500 Health System, Health Plan, Pharmaceutical, and Government Clinical IT Innovation Leaders to discuss best practices for transformation, collaboration, and the implementation of evidence-based digital health applications.

Read on digitalmedicineconference.com

Manhattan, United States of America

Read on medicaleventsguide.com

The 12th Annual Conference on the Science of Dissemination and Implementation in Health (D&I), co-hosted by the National Institutes of Health (NIH) and AcademyHealth, will take place December 4-6, 2019 at the Crystal Gateway Marriott, in Arlington, VA.This December, more than 1,200 individuals will convene in the nation’s capital to ensure that evidence is used to inform decisions that will improve the health of individuals and communities. This year’s conference theme, Raising the Bar on the Rigor, Relevance, and Rapidity of Dissemination and Implementation Science, is intended to help us map the way forward for improvements in the development, execution and application of D&I science.

Read more 

Health related stigma destroys human dignity. Stigma, when associated with HIV, another medical condition, mental illness or disability, prevents a person from seeking evaluation and treatment, disclosing the diagnosis to those most likely to provide support, and following treatment guidelines.

Read on whocanyoutell.org

We are pleased to invite you to join us this fall for the 19th Annual Diabetes Technology Meeting, from November 14 to November 16, 2019, at the Bethesda North Marriott Hotel & Conference Center in North Bethesda, Maryland.

This will be an excellent opportunity to meet leading scientists in the field of diabetes research and learn about the latest technological advances for people with diabetes. Last year's meeting in Bethesda, Maryland brought together over 500 clinicians and scientists from 21 countries to focus on applying science and technology to fight diabetes.

The meeting’s goal is to assemble technology developers and users to facilitate the creation of new and cost-effective tools to help people with diabetes. FDA officials will participate to update attendees on current US regulatory policies.  The meeting will particularly emphasize original data. Scientists and clinicians will have plenty of opportunities to share ideas in both formal and informal setting.

The format will include state-of-the-art lectures, oral presentations of abstracts, panel discussions with Q & A sessions, and two poster sessions. The submitted abstracts will be available to all attendees.

Every attendee will receive a one-year subscription to Journal of Diabetes Science and Technology. This peer-reviewed bimonthly scientific journal is indexed by the National Library of Medicine for MEDLINE/PubMed and is the world's first purely electronic diabetes journal (http://journals.sagepub.com/home/dst).

We look forward to seeing you in Bethesda and sharing information about projects of mutual interest.

Read more on https://www.diabetestechnology.org/dtm/agenda.shtml